SS
Shweta Singh
About Shweta Singh
Data last updated:
Shweta Singh has 5 years in corporate governance. Holds Designated Partner and Director roles. Currently with 2 companies, including Deveon Biotech Llp and Aricon Pharma Private Limited. Engaged in Technology, General Business. Contributes to corporate operations. The largest current company by reported revenue is Aricon Pharma Private Limited at ₹27.4 Lakh (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 19 Mar 2021 | 2016 | ₹27.4 Lakh (FY 2024) | Active | |
| Designated Partner | 07 Jun 2022 | 2022 | – | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Shweta Singh
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Shweta Singh
Shweta Singh has 5 years in corporate governance. Holds Designated Partner and Director roles. Currently with 2 companies, including Deveon Biotech Llp and Aricon Pharma Private Limited. Engaged in Technology, General Business. Contributes to corporate operations. The largest current company by reported revenue is Aricon Pharma Private Limited at ₹27.4 Lakh (FY 2024).
Shweta Singh is associated with 2 companies as Designated Partner and Director, including Aricon Pharma Private Limited (₹27.4 Lakh), Deveon Biotech Llp.
Shweta Singh has expertise in Technology, General Business.
Shweta Singh has 5 years in corporate governance.
By reported revenue, the largest current company of Shweta Singh is Aricon Pharma Private Limited, with revenue of ₹27.4 Lakh (FY 2024).
Shweta Singh currently holds positions at 2 companies: Aricon Pharma Private Limited (₹27.4 Lakh), Deveon Biotech Llp.